Mark Wilterding

Chief Financial Officer

Chief Financial Officer at RxSight, Inc., filing insider transactions on 2026-09-02.

Total Purchases

—

0 transactions

Total Sales

$54K

1 transaction

Companies Traded

1

1 total filings

Active Since

2026-09-02

Last: 2026-09-02

Companies

RxSight, Inc.

Other Reporting Insiders at RxSight, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-02	RXST	Sale	7,765	$6.96	$54K	25.0K	SEC ↗

Mark Wilterding (RxSight, Inc.) Insider Trades | Tormere